¸Î°©Êǵڶþ´ó°©Ö¢£¬ÓëÆäËûÖ×ÁöÏà±È£¬¸Î°©·¢ÉúµÄÓÕÒò³£ÓÉÓÚ³¤ÆÚµÄ¸ÎÔàÂýÐÔÑ×Ö¢£¬ÈçÂýÐÔÒÒÐ͸ÎÑס¢·Ç¾Æ¾«ÐÔÖ¬·¾¸ÎÑ׵ȡ£ÔÚÓÕµ¼Ñ×Ö¢·¢Õ¹³ÉÖ×ÁöµÄÖÚ¶àÒòËØÖУ¬Ñ×ÐÔ΢»·¾³µÄ²îÒì
2019-08-01
³É¹û²©ÀÀ
Sport >³É¹û²©ÀÀ >
´óÄÔÖеÄÉñ¾ÔªµÄÊ÷Í»¾ßÓи´Ôӵļ¸ºÎÐÎ̬ºÍÉúÎïÎïÀíÌØÐÔ£¬Ä¿Ç°½ÏΪÁ÷ÐеÄÉñ¾ÔªÀíÂÛÄ£ÐÍͨ³£²»¿¼ÂÇÊ÷Í»½á¹¹£¬½«Éñ¾ÔªµÄ¼¸ºÎÐÎ̬¼ò»¯ÎªÒ»¸öµãÀ´ÃèÊöÉñ¾ÔªµÄϸ°ûÌå(µãÉñ¾
2019-07-16
³É¹û²©ÀÀ
Thermo ScientificSport¼ø¶¨ºÍÒ©Ãô·ÖÎöϵͳ£¬ÌṩÁé»î·½±ãµÄ±ê×¼°åºÍÓû§¶¨Öư壬Êʺϸ÷ÖÖ¹æÄ£µÄʵÑéÊÒ¡£ÏȽøµÄÓ«¹â¼ì²â¼¼Êõ£¬Ó¦ÓÃÓÚSport¼ø¶¨¼°Ò©Ãô²â
2019-07-11
³É¹û²©ÀÀ
´óÄÔÆ¤²ãÊÇÓɲ»Í¬ÀàÐÍÉñ¾Ï¸°ûÏ໥Á¬½Ó×é³ÉµÄ¸ß¶È¸´ÔÓÉñ¾ÍøÂ磬Æä½âÆÊ½á¹¹ÊÇÐÅÏ¢ÔÚÄÔÖд«µÝµÄ»ù´¡¡£ÎªÀí½â´óÄÔÄÚÉñ¾ÐÅÏ¢µÄ´¦Àí»úÖÆ£¬ÔÚÕû¸öƤ²ãÉõÖÁÈ«ÄÔ·¶Î§Òª¶ÔÉñ¾»·Â·
2019-07-10
³É¹û²©ÀÀ
CRISpR CasϵͳÊǹ㷺´æÔÚÓÚϸ¾úºÍ¹Å¾úÖеĵֿ¹²¡¶¾ºÍÍâÔ´ÖÊÁ£ÈëÇֵĻñµÃÐÔÃâÒß·ÀÓùϵͳ¡£CRISpR-Casϵͳ·ÖΪÁ½´óÀà¡£µÚÒ»´óÀàCRISpR-Casϵ
2019-07-09
³É¹û²©ÀÀ
Ëæ×Ŷþ´ú²âÐò³É±¾µÄ²»¶Ï½µµÍÒÔ¼°Èý´ú¡¢ËÄ´ú²âÐò¼¼ÊõµÄ¿ìËÙ·¢Õ¹£¬Ô½À´Ô½¶àÉúÎïÎïÖÖµÄÈ«»ùÒò×éÐòÁб»½â¶Á³öÀ´£¬¶à×éѧÊý¾Ý³ÊÏÖ±¬·¢ÐÔÔö³¤µÄÌ¬ÊÆ¡£È»¶ø£¬Êý¾ÝµÄ¸ßЧÍÚ¾òºÍÉî¶È
2019-07-03
³É¹û²©ÀÀ
Illumina¹«Ë¾½üÈÕÐû²¼£¬ËüÒѾÓëÖйú·Ö×ÓÕï¶Ï¹«Ë¾»ù×¼Ò½ÁÆ£¨AnchorDx£©´ï³ÉÕ½ÂÔºÏ×÷ÐÒ飬¹²Í¬ÎªÖйúÊг¡¿ª·¢ÁÙ´²Ö×Áöѧ¼ì²â²úÆ·¡£¸ù¾ÝºÏ×÷ÐÒ飬×ܲ¿Î»ÓÚ
2019-07-01
³É¹û²©ÀÀ
ÄÏ·½¿Æ¼¼´óѧ»·¾³¿ÆÑ§Ó빤³ÌѧԺÖúÀí½ÌÊÚÍõ¿¡¼áÓëºÏ×÷ÕßÔÚ¹ú¼Ê¶¥¼âѧÊõÆÚ¿¯¡¶×ÔȻͨѶ¡·£¨Nature Communications£©ÉÏ·¢±íÁËÌâΪ¡°Nonlinear
2019-06-26
³É¹û²©ÀÀ
ÐÄѪ¹Ü¼²²¡ÊÇÑÏÖØÎ£º¦ÈËÀཡ¿µµÄÍ·ºÅɱÊÖ¡£¾Ýͳ¼Æ,È«ÇòÿÄêÔ¼ÓÐ1700ÍòÈËËÀÓÚÐÄѪ¹Ü¼²²¡;ÔÚÖйúÿÄêÔ¼ÓÐ300ÍòÈËËÀÓÚÐÄѪ¹Ü¼²²¡£¬Õ¼×ÜËÀÍöÔÒòµÄ41%£¬¶øÇÒÆäËÀÍö
2019-06-24
³É¹û²©ÀÀ
Antibody-drug conjugate development has seen real progression over the last year
2019-06-10
³É¹û²©ÀÀ
ת¼µ÷¿ØÊǸÉϸ°û¹¦ÄܺÍÔçÆÚÅßÌ¥·¢ÓýµÄºËÐĹý³Ì¡£ÅßÌ¥¸Éϸ°û¶àÄÜÐÔµÄά³ÖÐèҪϸ°û±£³Ö¸ßˮƽµÄת¼ºÍºËÌÇÌåÉú³É»îÐÔ£¬ÆÆ»µÏ¸°ûÕý³£µÄת¼ºÍºËÌÇÌåÉú³É״̬¶¼»áµ¼ÖÂÅßÌ¥¸Éϸ
2019-06-04
³É¹û²©ÀÀ
ðåÕ¶¾ÔÚ×ÔÈ»½çÖй㷺´æÔÚ£¬ÔÚ¸ÐȾÈËÌåºóÄܹ»Òý·¢¶àÖÖ¼²²¡£¬°üÀ¨´ø×´ðåÕî¡¢³öÉúȱÏÝ¡¢¶àÖÖÃâÒßϵͳ¼²²¡ÒÔ¼°°©Ö¢¡£ðåÕ¶¾°üÀ¨ÄÒĤ¡¢ÖмäÌåµ°°×²ã¡¢Ò¿ǺͻùÒò×éËIJã½á¹¹
2019-05-30
³É¹û²©ÀÀ
EMTÊÇÉÏÆ¤Ï¸°û»ñµÃ¼ä³äÖÊϸ°ûÌØÖʵÄÒ»ÖÖÖØÒªÏÖÏ󣬼´Ï¸°û»ñµÃ¾ßÓÐÏËάĸϸ°ûÑùµÄÐÎ̬£¬ÔöÇ¿µÄÔ˶¯ÐÔ£¬Í¨¹ý¶ªÊ§ð¤¸½ÐԺͽôÃÜÁ¬½Ó£¬¿çÔ½»ùĤÓëÁÚ½üϸ°û½øÐн»Á÷¡£EMTµÄ
2019-05-29
³É¹û²©ÀÀ
ͬ¼Ã´óѧÉúÎïÐÅϢϵÁõçù½ÌÊÚ¿ÎÌâ×é½üÈճɹ¦¿ª·¢ÁË»ùÓÚÈ˹¤ÖÇÄÜÖ÷ÌâÄ£ÐÍ(Topic Modeling)µÄµ¥Ï¸°ûCRISpRɸѡÊý¾ÝµÄ·ÖÎö·½·¨¡£Ïà¹ØÑо¿ÂÛÎÄ¡¶Mode
2019-05-28
³É¹û²©ÀÀ
2019Äê5ÔÂ15ÈÕ£¬ÉϺ£¡ª¡ª½ñÈÕ£¬¿ÆÑ§·þÎñÁìÓòµÄÊÀ½çÁìµ¼ÕßÈüĬ·ÉÊÀ¶û¿Æ¼¼£¨ÒÔϼò³Æ£ºÈüĬ·É£©ÓëÉϺ£½õ˹ÉúÎï¼¼ÊõÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ£º½õ˹ÉúÎǩÊðÁËÕ½ÂÔºÏ×÷ÐÒé
2019-05-16
³É¹û²©ÀÀ
ôßÄÏ´óѧÕŹ½ÌÊںͻªÄÏÀí¹¤´óѧÁÖÓ°½ÌÊÚÔÚBiotechnology for BiofuelsÔÓÖ¾£¨ÉúÎ﹤³ÌÀàÒ»Çø£©ÉÏ·¢±íÎÄÕ£¬Ê¹Ó÷ÒëÈ«¾Ö¿ØÖÆ·½·¨£¬¸ÄÉÆÍâÔ´µ°°×
2019-05-13
³É¹û²©ÀÀ
½üÈÕ£¬É½¶«´óѧµÄÕÔ¼Ò¾üºÍÕÅȺҵÍŶÓÔÚ¡¶Journal of Experimental Medicine¡·ÔÓÖ¾ÉÏ·¢±íÁËÌâΪ¡°Thyrotropin aggrava
2019-04-26
³É¹û²©ÀÀ
¶ùͯ¼±ÐÔÁܰÍϸ°û°×Ѫ²¡£¨ALL£©ÊǶùͯ×î³£¼û¶ñÐÔÖ×ÁöÖ®Ò»£¬ÏÖ½×¶ÎÎÒ¹ú¶ùͯALLµÄÖÎÓúÂÊԼΪ70%£¨¹ú¼Ê×î¸ßÖÎÓúÂÊԼΪ80%£©¡£»¼Õß¶ÔÏà¹ØÖÎÁÆÒ©ÎïµÄÄÍÒ©ÐÔÒÔ¼°ÓÉ´Ë
2019-04-22
³É¹û²©ÀÀ
Ëæ×ÅÎÒ¹úÀÏÁ仯µÄ¼ÓËÙ£¬50ËêÒÔÉÏÈËȺ¹ÇÖÊÊèËÉÖ¢»¼²¡Âʸߴï19 2%¡£Ä¿Ç°Ó¦ÓÃÓÚÁÙ´²Î¨Ò»¸ßЧ´Ù½ø¹ÇÐγÉÒ©Îï-¼××´ÅÔÏÙ¼¤ËØpTH£¬´æÔÚ×ÅÁ½ÄêʹÓÃʱÏÞ¡¢¹ÇÕÛÖÎÁƲ»Ãô¸Ð
2019-04-10
³É¹û²©ÀÀ
×ÔÈ»½çÖдæÔÚ×ŷḻ¶àÑùµÄÉúÎï×Ô×é֯ϵͳ£¬±íÏÖ³ö¸ß¶ÈµÄȺÌåÖǻۣ¬¿ÉÒÔ½â¾ö¸öÌåÎÞ·¨Ê¤Èεĸ´ÔÓÎÊÌâ¡£±ÈÈç·Ö¹¤Ð×÷µÄÒÏȺ¿É¹¹½¨¸´ÔÓ¶ø¾«ÇɵÄÒϳ²¡¢°áÔ˳¬ÖØÁÔÎ²¼Õó²¶Ê³µÄ
2019-04-03
³É¹û²©ÀÀ